WeLeader Biomedical Co., Ltd. (TPEX:7713)

Taiwan · Delayed Price · Currency is TWD

68.30

-1.10 (-1.59%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Adjustments and Write-Offs	-5.02M	-267.00K	-904.00K	-3.23M	-3.85M
The Company	921.45M	825.01M	786.04M	873.39M	742.56M
The Company Growth	11.69%	4.96%	-10.00%	17.62%	-
Premium Product	192.86M	166.38M	155.57M	165.55M	102.42M
Premium Product Growth	15.92%	6.95%	-6.03%	61.64%	-
Total	1.11B	991.13M	940.70M	1.04B	841.14M
Total Growth	11.92%	5.36%	-9.17%	23.13%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Taiwan	1.11B	991.13M	940.70M	1.04B	841.14M
Taiwan Growth	11.92%	5.36%	-9.17%	23.13%	-
Total	1.11B	991.13M	940.70M	1.04B	841.14M
Total Growth	11.92%	5.36%	-9.17%	23.13%	-

Source: S&P Global Market Intelligence.